Hims & Hers Health (NYSE: HIMS) is one of the fastest-growing stocks in the healthcare industry. While it has started out by focusing on niches and helping people with sensitive issues such as erectile dysfunction, it is branching out into larger areas, which can lead to much more growth in the future.

The company recently released its quarterly results and yet again demonstrated impressive numbers. And not only that, but Hims & Hers also raised its forecast. Is now the time to buy the stock before it takes off?

Hims & Hers isn't a terribly large healthcare company; its market cap is around $1.6 billion. But this is an intriguing stock for investors because of its impressive growth. It reported its third-quarter numbers earlier this month, and sales of $226.7 million  were up 57% year over year. And that's actually lower than the growth rates it has posted in other recent quarters.

Continue reading

Source Fool.com